InvestorsHub Logo
icon url

StocktraderDK

11/30/21 8:22 AM

#1874 RE: StocktraderDK #1873

$HEPA FDA consider crv431 a drug with excellent efficacy and safety profile to potentially treat Nash. A very good support from FDA to Hepion.